title: Urokinase gene expression indicates early invasive growth in squamous cell lesions of the uterine cervix.
abstract: The plasminogen activating system plays a key role in the cascade of tumour-associated proteolysis leading to extracellular matrix degradation and stromal invasion. Changes in the expression of this system, consisting of urokinase- and tissue-type plasminogen activators (uPA and tPA, respectively), plasminogen activator inhibitors (PAI-1, PAI-2) and uPA receptor, have been associated with tumour aggressiveness in a variety of solid malignant tumours. This paper describes a study of squamous intraepithelial lesions (SILs, n=36), squamous cell carcinomas (SCCs, n=42), and normal mucosa (n=5) of the uterine cervix by in situ hybridization with (35)S-labelled RNA probes. uPA transcripts were absent from normal mucosa and non-invasive lesions, but present in atypical epithelial cells of all microinvasive carcinomas ( n=19) and in some of the more advanced invasive carcinomas (n=11). PAI-1 transcripts were found in stromal cells of most tissue samples with, however, significantly increased levels in invasive SCC compared with SIL, microinvasive SCC, and normal mucosa. uPA-positive invasive carcinomas often displayed additional PAI-1 expression by tumour cells. At variance with uPA, tPA transcripts were found in atypical epithelial cells of low- and high-grade SILs. In the majority of SCCs tested (27/29 cases), the HPV 16 E6/E7 oncogene and uPA transcription were correlated. uPA and PAI-1 expression indicates invasive growth when expressed by atypical epithelial cells of squamous cervical lesions. Moreover, the presence of uPA transcripts is indicative of early invasive growth. uPA and tPA seem to have different functions in the development of invasive properties in uterine cervical squamous epithelium.
authors.affiliation: Department of Gynecopathology, University of Hamburg, 20246 Hamburg, Germany. riethdor@plexus.uke.uni-hamburg.de
authors.forename: L
authors.initials: L
authors.lastname: Riethdorf
authors.forename: S
authors.initials: S
authors.lastname: Riethdorf
authors.forename: S
authors.initials: S
authors.lastname: Petersen
authors.forename: M
authors.initials: M
authors.lastname: Bauer
authors.forename: H
authors.initials: H
authors.lastname: Herbst
authors.forename: F
authors.initials: F
authors.lastname: Jänicke
authors.forename: T
authors.initials: T
authors.lastname: Löning
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000201:enzymology / Q000473:pathology* / Q000821:virology; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000378:metabolism*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014412:Tumor Virus Infections / Q000150:complications; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000201:enzymology / Q000473:pathology* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000201:enzymology / Q000473:pathology
chemical_list: D009363:Neoplasm Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator